| | 
Part, Chapter, Paragraph
1 II, 5. 1. 1| lipoprotein cholesterol, high blood pressure, diabetes, dyslipidemia
2 II, 5. 1. 1| obese or with high blood pressure or high cholesterol;~·
3 II, 5. 2.Acr| Cardiovascular Disease~DBP~Diastolic Blood Pressure~ESC~European Society
4 II, 5. 2.Acr| Angioplasty~SBP~Systolic Blood Pressure~WHO MONICA~World
5 II, 5. 2. 2| lipoprotein cholesterol, high blood pressure, diabetes, obesity).
6 II, 5. 2. 3| as serum cholesterol and blood pressure, and by the reduction
7 II, 5. 2. 4| simultaneous reductions in blood pressure, obesity, blood
8 II, 5. 2. 4| blood pressure, obesity, blood cholesterol and tobacco
9 II, 5. 2. 4| associated with high levels of blood pressure, LDL and total
10 II, 5. 2. 4| with CVD incidence (age, blood pressure, cholesterol, body
11 II, 5. 2. 4| and is strongly related to blood pressure, total and high-density
12 II, 5. 2. 4| show a decrease in systolic blood pressure in all participating
13 II, 5. 2. 4| mean values of systolic blood pressure (mmHg), total cholesterol (
14 II, 5. 2. 4| due to a history of high blood pressure, between 45% and
15 II, 5. 2. 4| attacks are due to abnormal blood lipids, and around 30% to
16 II, 5. 2. 5| smoking habit, systolic blood pressure, cholesterol and
17 II, 5. 2. 5| for LDL cholesterol and blood pressure in individuals
18 II, 5. 2. 5| 2007)~Within this context, blood lipid and blood pressure
19 II, 5. 2. 5| context, blood lipid and blood pressure control are the
20 II, 5. 2. 5| fail to bring the patient’s blood lipids or blood pressure
21 II, 5. 2. 5| patient’s blood lipids or blood pressure to the appropriate
22 II, 5. 2. 5| smoking, cholesterol and blood pressure. By 1992, CVD mortality
23 II, 5. 2. 6| smoking habit, cholesterol, blood pressure, obesity and physical
24 II, 5. 2. 6| cholesterol-carrying lipoproteins in blood in determining CVD risk
25 II, 5. 2. 6| considered for CVD prevention.~ ~Blood pressure and CVD risk~Elevated
26 II, 5. 2. 6| pressure and CVD risk~Elevated blood pressure levels are associated
27 II, 5. 2. 6| at any age, starting from blood pressure levels of 115 mmHg
28 II, 5. 2. 6| of 115 mmHg of systolic blood pressure (SBP) and from
29 II, 5. 2. 6| from 75 mmHg of diastolic blood pressure (DBP) (Lewington
30 II, 5. 2. 6| The CVD risk associated to blood pressure values around 130-
31 II, 5. 2. 6| than the risk associated to blood pressure values <120/80
32 II, 5. 2. 6| shown that a reduction of blood pressure causes a reduction
33 II, 5. 2. 6| physical activity can help to maintain blood pressure levels in the desired
34 II, 5. 2. 6| Age-specific relevance of usual blood pressure to vascular mortality:
35 II, 5. 2. 6| 1107.~Kannel WB (1996). Blood pressure as a cardiovascular
36 II, 5. 2. 6| Feskens EJ, Kromhout D (1996). Blood pressure and isolated systolic
37 II, 5. 2. 6| Prospective Studies Collaboration: Blood cholesterol and vascular
38 II, 5. 2. 6| mortality by age, sex, and blood pressure: a meta-analysis
39 II, 5. 2. 6| 2823-2828.~Turnbull F; Blood Pressure Lowering Treatment
40 II, 5. 2. 6| Impact of high-normal blood pressure on the risk of
41 II, 5. 2. 7| 419-425.~Sac p. Effects on blood pressure of reduced dietary
42 II, 5. 2. 7| in population levels of blood pressure and other cardiovascular
43 II, 5. 3. 7| colorectal cancer (faecal occult blood or FOB test). In Europe
44 II, 5. 3. 7| cancer and faecal occult blood for colorectal cancer. In
45 II, 5. 4. 1| especially eyes, kidneys, blood vessels, nerves and heart.
46 II, 5. 4. 1| with hypertension, (high blood pressure) and increased
47 II, 5. 4. 1| pressure) and increased blood levels of total cholesterol
48 II, 5. 4. 1| and triglycerides. High blood sugar levels (hyperglycaemia),
49 II, 5. 4. 1| complications, affecting both small blood vessels (macro-vascular
50 II, 5. 4. 1| kidney damage), and larger blood vessels (macro-vascular
51 II, 5. 4. 1| known major risk factor for blood vessel changes. Near normalisation
52 II, 5. 4. 1| changes. Near normalisation of blood glucose values as well as
53 II, 5. 4. 1| well as lipid levels and blood pressure are necessary to
54 II, 5. 4. 1| diabetes are as follows:~Feet: blood flow problems can cause
55 II, 5. 4. 1| sensation (nerve function) or blood flow, people with diabetes
56 II, 5. 4. 1| lead to amputations;~Eyes: blood flow problems can also interfere
57 II, 5. 4. 1| also interfere with the blood supply to the retina, leading
58 II, 5. 4. 1| blindness (retinopathy). High blood sugars, may also induce
59 II, 5. 4. 1| Kidneys: Over time, high blood glucose can cause damage
60 II, 5. 4. 1| cause damage to the small blood vessels in the kidneys,
61 II, 5. 4. 2| national indicators (e.g. blood pressure increase by classes
62 II, 5. 4. 2| physical examination and blood analysis. ~It is well known
63 II, 5. 4. 2| diabetic subjects with a tested blood pressure measurement in
64 II, 5. 4. 2| diabetic subjects with a tested blood pressure in the last 12
65 II, 5. 4. 2| diabetes, parameters include blood glucose management, blood
66 II, 5. 4. 2| blood glucose management, blood pressure, blood lipids,
67 II, 5. 4. 2| management, blood pressure, blood lipids, kidney functions
68 II, 5. 4. 2| defined) or a proteinuria.~Blood pressure control is measured
69 II, 5. 4. 2| subjects that had their blood pressure measured in the
70 II, 5. 4. 2| between the measurement of blood pressure and age.~Level
71 II, 5. 4. 2| pressure and age.~Level of blood pressure is measured as
72 II, 5. 4. 2| subjects that had their blood pressure measured in the
73 II, 5. 4. 2| and reported a diastolic blood pressure above 90 and/or
74 II, 5. 4. 2| above 90 and/or a systolic blood pressure above 140 mm Hg.~
75 II, 5. 4. 3| diabetes, parameters include blood glucose management, blood
76 II, 5. 4. 3| blood glucose management, blood pressure, blood lipids,
77 II, 5. 4. 3| management, blood pressure, blood lipids, kidney functions
78 II, 5. 4. 3| the age groups above 65.~Blood pressure control. In EUCID,
79 II, 5. 4. 3| 100% (Cyprus).~Level of blood pressure. The percentage
80 II, 5. 4. 5| type 2 diabetes are:~- high blood pressure or high cholesterol;~-
81 II, 5. 4. 6| important risk factor. For high blood pressure and high cholesterol,
82 II, 5. 4. 6| circumference, elevated blood pressure and hyperlipidaemia.
83 II, 5. 5. 3| ruptured oesophagus, high blood pressure, type 2 diabetes,
84 II, 5. 7. 1| abnormalities (proteinuria)~blood abnormalities (renal tubular
85 II, 5. 7. 7| Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
86 II, 5. 7. 7| disadvantage and change in blood pressure associated with
87 II, 5. 7. 7| and the QUEST initiative. Blood Purif 2007;25(3):219-20.~
88 II, 5. 7. 7| Evaluation, and Treatment of High Blood Pressure OQI clinical practice
89 II, 5. 7. 7| Cardiovascular Disease, High Blood Pressure Research, Clinical
90 II, 5. 9. 4| 641 0-to 17-year-olds, and blood samples were studied for
91 II, 5. 11. 1| structures including nails, hair, blood vessels, nerves, sweat and
92 II, 5. 13 | physical activity; these are high blood pressure, high blood cholesterol
93 II, 5. 13 | high blood pressure, high blood cholesterol level, high
94 II, 5. 15. 6| disease in Israel as a model. Blood Cells Mol Dis. 2006 Jul-Aug;
95 II, 6. 3. 2| isolates over total S. aureus blood stream infections in selected
96 II, 6. 3. 3| After 1994 transmission via blood transfusion and use of plasma-derived
97 II, 6. 3. 6| has been described through blood transfusion. Preventive
98 II, 6. 3. 6| animal food chains, and that blood or tissue for transplants
99 II, 6. 3. 6| transmission of vCJD through blood transfusion.~ ~Since 1995,
100 II, 6. 3. 7| organ transplantation and blood transfusion has been documented,
101 II, 6. 3. 7| through close contact with blood or body fluids. No treatment
102 II, 8. 2. 1| villus sampling, and various blood tests, can be performed
103 II, 9. 2. 1| obesity, diabetes, high blood pressure and cardiovascular
104 II, 9. 2. 3| central adiposity, raised HDL blood cholesterol, raised blood
105 II, 9. 2. 3| blood cholesterol, raised blood triglycerides, and raised
106 II, 9. 2. 3| triglycerides, and raised blood glucose levels (Lobstein
107 II, 9. 3. 1| is growing that lowering blood cholesterol levels and treating
108 II, 9. 3. 1| women had poorer control of blood pressure and a significantly
109 II, 9. 3. 1| significantly higher mean systolic blood pressure compared to men (
110 II, 9. 3. 1| modes in Western Europe are blood transfusion and intravenous
111 II, 9. 3. 1| communities, particularly among blood recipients and, more recently,
112 II, 9. 3. 1| then be considered. General blood chemistry and specific hormonal
113 II, 9. 3. 2| section) or embolisation (3) blood transfusion (4) hospitalization
114 III, 10. 1. 3| and their combination on blood pressure. J Hum Hypertens
115 III, 10. 2. 1| high cholesterol levels in blood and hypertension (Keil U,
116 III, 10. 2. 1| as well as an increase in blood pressure, respiration and
117 III, 10. 2. 1| use include increase of blood pressure, increased risk
118 III, 10. 2. 1| Alcohol Policy Network~BAC~Blood Alcohol Concentration~CHD~
119 III, 10. 2. 1| drinking occasions, as well as blood alcohol concentration levels.
120 III, 10. 2. 1| any departure from a zero blood alcohol concentration level (
121 III, 10. 2. 1| level (BAC). Comparison of blood alcohol concentrations (
122 III, 10. 2. 1| ill health. Alcohol raises blood pressure and increases the
123 III, 10. 2. 1| factor after tobacco and high blood pressure. This is mainly
124 III, 10. 2. 1| Setting and controlling blood alcohol levels.~ ~Establishing
125 III, 10. 2. 1| the customer’s estimated blood alcohol concentration (BAC)
126 III, 10. 2. 1| Recommendation on maximum permitted blood alcohol content, 2001~http ~ ~
127 III, 10. 2. 1| combined with the spread of blood borne diseases (mainly HIV/
128 III, 10. 2. 1| physical activity; these are high blood pressure, high blood cholesterol
129 III, 10. 2. 1| high blood pressure, high blood cholesterol level, high
130 III, 10. 2. 1| of serum insulin, a high blood level of low-density lipoprotein
131 III, 10. 2. 1| group. Higher homocysteine blood levels have indeed been
132 III, 10. 2. 3| 10.2.3. Blood pressure.~ ~Blood pressure
133 III, 10. 2. 3| 10.2.3. Blood pressure.~ ~Blood pressure level is associated
134 III, 10. 2. 3| systolic (SBP) and diastolic blood pressure (DBP) show a continuous
135 III, 10. 2. 3| progressively and linearly from blood pressure levels as low as
136 III, 10. 2. 3| CVD risk is associated to blood pressure values around 130-
137 III, 10. 2. 3| than the risk associated to blood pressure values <120/80
138 III, 10. 2. 3| subjects. A reduction of blood pressure causes a reduction
139 III, 10. 2. 3| physical activity can help to maintain blood pressure levels within the
140 III, 10. 2. 3| considered. Desired goals for blood pressure are <140/90 mmHg
141 III, 10. 2. 5| and adult risk for high blood pressure, type 2 diabetes,
142 III, 10. 2. 5| attachment showed augmented blood pressure in conjunction
143 III, 10. 2. 5| age, are:~ ~- increased blood levels of free fractions
144 III, 10. 2. 5| motility and gastro-intestinal blood flow as well as gastric
145 III, 10. 2. 5| orientation influences ambulatory blood pressure responses to everyday
146 III, 10. 3. 1| system such as increased blood pressure and increased risk
147 III, 10. 3. 1| between noise exposure and blood pressure and ischemic heart
148 III, 10. 3. 2| very successful in lowering blood lead levels in children
149 III, 10. 3. 3| has been described through blood transfusion. Preventive
150 III, 10. 3. 3| animal food chains, and that blood or tissue for transplants
151 III, 10. 3. 4| nervous system disorders, blood and metabolic or endocrine
152 III, 10. 4. 2| were also detected in cord blood. This means they are able
153 III, 10. 4. 2| human maternal and cord blood samples: Assessment of PFOS
154 IV, 11. 1. 5| include the setting of patient blood pressure and cholesterol
155 IV, 11. 5. 6| cells, human organs and blood used in medical treatment.
156 IV, 11. 5. 6| Directives have been adopted on blood (htt ), on tissues and on
157 IV, 11. 5. 6| on autologous cord blood banks and explanatory memorandum~
158 IV, 11. 5. 6| Creutzfeldt-Jakob Disease (vCJD) by blood transfusion ~1999 Meeting
159 IV, 12. 1 | substances of human origin, blood and blood derivatives; these
160 IV, 12. 1 | human origin, blood and blood derivatives; these measures
161 IV, 12. 1 | medical use of organs and blood.~ ~Art. 153 “The Community
162 IV, 12. 2 | Cardiovascular diseases (CVD)~ ~Blood lipid and blood pressure
163 IV, 12. 2 | CVD)~ ~Blood lipid and blood pressure control are the
164 IV, 12. 2 | for LDL cholesterol and blood pressure in individuals
165 IV, 12. 2 | fail to bring the patient’s blood lipids or blood pressure
166 IV, 12. 2 | patient’s blood lipids or blood pressure to the appropriate
167 IV, 12. 2 | smoking, cholesterol and blood pressure. By 1992, CVD mortality
168 IV, 12. 2 | cancer and faecal occult blood for colorectal cancer. In
169 IV, 12. 2 | and obesity and those high blood pressure and high cholesterol.
170 IV, 12. 2 | Setting and controlling blood alcohol levels.~ ~Establishing
171 IV, 12. 2 | the customer’s estimated blood alcohol concentration (BAC)
172 IV, 12. 2 | Recommendation on maximum permitted blood alcohol content, 2001~http
173 IV, 12. 5 | substances of human origin, blood, and blood derivatives;
174 IV, 12. 5 | human origin, blood, and blood derivatives; promote their
175 IV, 12. 10 | alcopop taxes). In general, blood alcohol concentration limits
176 IV, 12. 10 | the fight against lead in blood in children~Transportation
177 IV, 12. 10 | consultation the GP examines the blood pressure~Decreasing the
178 IV, 12. 10 | the fight against lead in blood in children~Transportation
179 IV, 12. 10 | consultation the GP examines the blood pressure~Decreasing the
180 IV, 13. 2. 3| Hypertension, unfavourable blood lipid composition and obesity
181 IV, 13. 2. 4| are smoking, having a high blood pressure, drinking too much
182 IV, 13. 2. 4| alcohol, overweight, high blood levels of cholesterol and
183 IV, 13. 7 | technologies possible. Human blood and its components can be
184 IV, 13. 7 | quality and safety of human blood and blood components were
185 IV, 13. 7 | safety of human blood and blood components were introduced
186 Key, Ap5. 0. 0| bleeding~blind~blindness~blood~blood-borne~bluetongue~body weight~
|
|
| |
